# Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children

> **NCT02328768** · — · APPROVED_FOR_MARKETING · sponsor: **University of Nebraska**

## Conditions studied

- Total Parenteral Nutrition-Induced Cholestasis

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT02328768
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02328768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02328768, "Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02328768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*